Data-driven analysis from the healthcare B2B failure corpus.
March 28, 2026 · 2 min read
{{competitive_displacement_count}} companies in our corpus failed from competitive displacement — more than any other failure node. Here's what the data shows about why healthcare incumbents are so hard to unseat.
March 25, 2026 · 2 min read
{{reimbursement_dependency_count}} healthcare startups in our corpus failed because their business model depended on reimbursement codes that didn't exist or didn't pay enough. The pattern is especially lethal in digital therapeutics.
March 20, 2026 · 2 min read
{{cac_payback_count}} healthcare B2B startups in our corpus failed because customer acquisition costs exceeded what the business model could sustain. The healthcare sales cycle is the structural driver.
March 15, 2026 · 2 min read
{{regulatory_scope_creep_count}} healthcare startups failed when regulatory requirements expanded beyond what their product architecture and team could handle. The pattern shows up most in compliance & regulatory and clinical workflow.